about
Gender differences in autoimmune disease.Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral SclerosisNeural agrin: a synaptic stabiliser.Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis.Muscle specific kinase: organiser of synaptic membrane domains.Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis.The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic β-cells, glycemic control and inflammation: In vitro and in vivo studiesAltered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression.Neuregulin-1 potentiates agrin-induced acetylcholine receptor clustering through muscle-specific kinase phosphorylation.Development of a high-throughput method for real-time assessment of cellular metabolism in intact long skeletal muscle fibre bundles.Neural agrin increases postsynaptic ACh receptor packing by elevating rapsyn protein at the mouse neuromuscular synapse.Rapsyn interaction with calpain stabilizes AChR clusters at the neuromuscular junction.Neuregulin potentiates agrin-induced acetylcholine receptor clustering in myotubes.Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice.Solving the alpha-conotoxin folding problem: efficient selenium-directed on-resin generation of more potent and stable nicotinic acetylcholine receptor antagonists.Growth hormone secretion is correlated with neuromuscular innervation rather than motor neuron number in early-symptomatic male amyotrophic lateral sclerosis mice.Increased adiposity and insulin correlates with the progressive suppression of pulsatile GH secretion during weight gain.The decline in pulsatile GH secretion throughout early adulthood in mice is exacerbated by dietary-induced weight gain.Dysregulation of microRNA biogenesis machinery and microRNA/RNA ratio in skeletal muscle of amyotrophic lateral sclerosis mice.Endocrine rhythms of growth hormone release: Insights from animal studies.17α-estradiol acts through hypothalamic pro-opiomelanocortin expressing neurons to reduce feeding behavior.Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease.The relationship between Bayesian motor unit number estimation and histological measurements of motor neurons in wild-type and SOD1(G93A) mice.Anthropometric measures are not accurate predictors of fat mass in ALS.Effect of Deletion of Ghrelin-O-Acyltransferase on the Pulsatile Release of Growth Hormone in Mice.Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis.Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosisBiomarkers of Metabolism in Amyotrophic Lateral SclerosisHypermetabolism in ALS is associated with greater functional decline and shorter survivalSignificant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosisExploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventionsPatient with ALS with a novel TBK1 mutation, widespread brain involvement, behaviour changes and metabolic dysfunctionGut microbiota in ALS: possible role in pathogenesis?Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis
P50
Q34040802-E7356E88-7DD5-4B34-9EBA-A03171CBFEC3Q36114275-CE85F2AC-4337-4363-BFA2-A2078ABE949DQ36663472-3F3D4B0A-E96F-4C55-95C7-F74B998A9BA5Q37449093-2CFCE1F7-77DE-4470-AD3E-243DF7E479E3Q37802950-4D730BB0-0BDF-4101-9BCE-6A59C3D90D45Q38195974-7371035E-7D08-4917-867D-BC4DA23E360AQ38577066-78438223-B7D9-4571-96B2-972BF5B0C6FFQ38740027-E47C24CC-A0A5-43C7-BA16-8DCDDDF77C87Q38892519-28F1DD22-D31E-4E15-BF04-02DF6F81EED9Q39397544-88239C56-4D47-4B19-9182-6E79629E020EQ39399897-4C9A9CE2-0960-43E5-9140-09FD6B82379CQ39978084-9A363AEB-0509-4DEE-BAB4-63F78DA34BCEQ40104987-9A7B692F-B597-487E-B0BE-2CF98FE899B0Q40493409-76590BB7-C27F-49E1-871A-4BB26E2B3564Q41701081-80781C34-D60F-4512-A3A8-408D9CAC0394Q42984437-DFD09020-763B-4F7E-91BA-D930F2DD881FQ43159292-39F2955A-D8B3-4F7E-94DC-0F648F92828DQ44761953-73FA1286-FEFE-4254-8A06-A3F6B59838C4Q47233370-4EE38B68-4732-4C52-8E72-5A7857186417Q47297343-BED1B543-2D62-45C8-A638-18CFD6C93C32Q47918174-9BC4CA72-9F0C-4E1E-BC98-E82D643C1F8BQ47924140-6E585994-616F-4BD2-B564-28BEAE255C8EQ47953999-28654029-2B4D-4036-A0CD-CCA629A27ADCQ49334640-96CAE089-66BC-45A7-8109-A296AF341029Q51377486-7C5E9B00-B18C-41DE-885A-0AA5983A9A42Q52097288-A8C25CF0-698A-4D8F-B9E3-2E90E10CF426Q52148370-BF6456A2-4EE6-4FE2-9ECB-AEBBC63B788DQ52625665-064665B1-2858-4E8B-B060-DC9C634E34DBQ60324733-5D62EF9F-86E0-4C8D-A43A-1B24B1E3F574Q64079740-084D6197-A478-41F5-84B0-25F231710EB9Q88506724-8D454397-1C6A-4C0A-98A2-AE4F31B85F9DQ90093652-9A5878DD-ACD7-4905-A3C9-2959D799856AQ90531525-85A21132-7546-4450-B66E-FCA9A547D217Q91342585-060A5E08-FF06-44B6-94A2-9F96E0289990Q92248110-00C0CABB-55DE-4A2C-81D7-C182BFDBF6EFQ92392938-AAF89044-2E5F-4D66-94A7-C6B25162147A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1388-2108
@en
name
Shyuan T Ngo
@ast
Shyuan T Ngo
@en
Shyuan T Ngo
@es
Shyuan T Ngo
@nl
type
label
Shyuan T Ngo
@ast
Shyuan T Ngo
@en
Shyuan T Ngo
@es
Shyuan T Ngo
@nl
prefLabel
Shyuan T Ngo
@ast
Shyuan T Ngo
@en
Shyuan T Ngo
@es
Shyuan T Ngo
@nl
P108
P106
P108
P1153
56878647400
7003395267
P31
P496
0000-0002-1388-2108